Satya is a discovery biotech, developing next-generation small-molecule oncology therapeutics that focus on unique approaches to Modulate proven oncogenic drivers, Tumor suppressors and Synthetic lethality Satya has a world-class scientific and executive team with a successful track record of translating >75 research programs to over 15 clinical candidates across oncology and inflammatory disorders Satya's Scientific Advisory Board comprises seasoned and accomplished scientists, with expertise in relevant scientific areas, and drawn from both industry and academia